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Cross-linking combined with mass spectrometry is an
emerging approach for studying protein structure and
protein-protein interactions. However, unambiguous
mass spectrometric identification of cross-linked pep-
tides derived from proteolytically digested cross-linked
proteins is still challenging. Here we describe the use of
a novel cross-linker, bimane bisthiopropionic acid N-
succinimidyl ester (BiPS), that overcomes many of the
challenges associated with other cross-linking re-
agents. BiPS is distinguished from other cross-linkers
by a unique combination of properties: it is photocleav-
able, fluorescent, homobifunctional, amine-reactive,
and isotopically coded. As demonstrated with a model
protein complex, RNase S, the fluorescent moiety of
BiPS allows for sensitive and specific monitoring of the
different cross-linking steps, including detection and
isolation of cross-linked proteins by gel electrophoresis,
determination of in-gel digestion completion, and fluo-
rescence-based separation of cross-linked peptides by
HPLC. The isotopic coding of BiPS results in character-
istic ion signal “doublets” in mass spectra, thereby
permitting ready detection of cross-linker-containing
peptides. Under MALDI-MS conditions, partial photo-
cleavage of the cross-linker occurs, releasing the cross-
linked peptides. This allows differentiation between
dead-end, intra-, and interpeptide cross-links based on
losses of specific mass fragments. It also allows the use
of the isotope doublets as mass spectrometric “signa-
tures.” A software program was developed that permits
automatic cross-link identification and assignment of
the cross-link type. Furthermore photocleavage of BiPS
assists in cross-link identification by allowing separate
tandem mass spectrometry sequencing of each peptide
comprising the original cross-link. By combining the use
of BiPS with MS, we have provided the first direct evi-
dence for the docking site of a phosphorylated G-pro-
tein-coupled receptor C terminus on the multifunctional
adaptor protein -arrestin, clearly demonstrating the
broad potential and application of this novel cross-linker
in structural and cellular biology. Molecular & Cellular
Proteomics 8:273–286, 2009.
Numerous cellular processes involve stable or transient
protein-protein interactions. Deciphering protein interaction
networks and the organization of protein complexes, such as
those involved in G-protein-coupled receptor and -arrestin
signaling, is a major focus of modern proteomics and cellular
biology. An important emerging technology for the structural
analysis of proteins and protein complexes involves cross-
linking combined with advanced mass spectrometric tech-
niques (1–4). This approach typically involves proteolysis of
complexed proteins followed by mass spectrometric identifi-
cation of the cross-linked peptides (also called “cross-links”)
(5).
Unfortunately, experiments combining cross-linking with
mass spectrometry involve many technical challenges. For
example, the combinatorial nature of protein cross-links cre-
ates an intrinsic problem of identification when assayed by
mass alone. Additionally insufficient fragmentation of cross-
linked peptides during MS/MS sequencing often results in
mass spectra that are difficult to interpret. The relatively low
number of cross-links compared with non-cross-linker-con-
taining peptides produced during proteolysis of the protein
complex presents another analytical challenge.
Several recent developments have resolved some of these
issues. Mass spectrometers capable of determining molecu-
lar weight with high mass accuracy, such as FTICR-MS in-
struments, reduce the number of potential cross-links that
can be assigned to a specific mass (1, 6). Also the specific
mass spectrometric “signature” provided by isotopically
coded cross-linkers (7) and isotope labeling of cross-links
during proteolysis (8) has been a crucial development for
straightforward MS detection of cross-links. We recently re-
ported an isotopically coded, chemically cleavable cross-
linker that allows discrimination between cross-link types
(dead end, intrapeptide, or interpeptide) and facilitates sub-
sequent MS/MS sequencing of the individual peptides that
constitute an interpeptide cross-link (9). We have also re-
ported a specific photocleavage of fluorescent monobromo-
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bimane (MBB)1-labeled cysteine residues that occurs under
MALDI conditions (10).
Based on this observation, we designed a cross-linker
called BiPS (bimane bisthiopropionic acid N-succinimidyl es-
ter) that is structurally similar to MBB-modified cysteine and
can therefore be photocleaved under MALDI conditions (see
Fig. 1A). Eight deuterium atoms were incorporated into the
structure of H8-BiPS (D8-BiPS) to assist in the detection of
both the cross-links and the peptides obtained after photo-
cleavage when a 1:1 mixture of H8-BiPS and D8-BiPS is used.
H8-BiPS/D8-BiPS mixtures thus allow complementary detec-
tion of the cross-links by fluorescence and by MS. Laser-
induced photocleavage of the cross-linker facilitates cross-
link identification and cross-link type assignment by a
combination of accurate mass and MS/MS sequencing of
each individual peptide. These characteristics make this novel
cross-linker a powerful tool for studying protein structure and
protein-protein interactions. Here we report a proof-of-princi-
ple study of the interaction of G-protein-coupled receptors
(GPCRs) and -arrestins using our novel cross-linker. GPCRs,
also referred to as “seven membrane-spanning receptors,”
constitute the largest known family of cell surface receptors.
These proteins are common targets of modern drug therapy
because they mediate a diverse group of intercellular signal-
ing events (11). The dynamic sensitivity of GPCR function and
signaling is due in large part to their regulation by the G-
protein-coupled receptor kinase/-arrestin system. Upon ag-
onist activation, G-protein-coupled receptor kinase-mediated
phosphorylation of the C terminus of the receptor initiates
binding of the multifunctional adaptor and transducer pro-
teins, the -arrestins, to the receptor. This interaction leads to
the desensitization of G-protein-mediated signaling, internal-
ization of the receptor, and activation of a growing list of
-arrestin-dependent signaling cascades and cellular pro-
cesses. However, little is known about the structural basis of
this interaction. Although a complete elucidation of the struc-
tural basis must await resolution of the atomic structure of the
receptor--arrestin complex, our structural proteomics meth-
odology (combining MS with the novel BiPS cross-linker) has
provided new direct structural information on the interaction
between GPCR and -arrestin.
EXPERIMENTAL PROCEDURES
Synthesis of BiPS/D8-BiPS
All reagents were purchased from Sigma-Aldrich unless otherwise
noted. BiPS cross-linker was synthesized by mixing mercaptopropi-
onic acid and dibromobimane followed by activation with N-hydroxy-
succinimide. Mercaptopropionic and d4-mercaptopropionic acids
were synthesized as described elsewhere (12). Briefly bromopropi-
onic acid (0.65 mmol) or d4-bromopropionic acid (C/D/N Isotopes
Inc.) was mixed with 0.65 mmol of thiourea and 200 l of water or
D2O, respectively. The mixture was heated for 2 h at 99 °C, and 100
l of 40% (w/w) NaOH or NaOD (Isotec) was then added and incu-
bated for 1 h at 99 °C in a Thermomixer (Eppendorf). Each preparation
was adjusted to pH 8 with HCl, and 0.1 mmol of dibromobimane
(Calbiochem) was added. The solution was mixed until completely
dissolved and kept at room temperature for 1 h. The pH was adjusted
to 8 by addition of NaOH (for H8-BiPS) or NaOD (for D8-BiPS).
Bimane bisthiopropionic acid was precipitated by addition of HCl,
filtered, washed with 1 mM HCl, and lyophilized. Equal amounts of H8-
and D8-dicarboxylic acids were mixed, dissolved in DMSO, and ac-
tivated with N-hydroxysuccinimide and dicyclohexylcarbodiimide
overnight at room temperature. The reaction mixture was then filtered,
and BiPS was precipitated by the addition of water, washed with
water, and lyophilized. BiPS and its deuterated derivative were char-
acterized by nano-ESI (QSTAR, Applied Biosystems, Framingham,
MA) under the experimental conditions and parameter settings de-
scribed elsewhere (13).
Protein Cross-linking Procedure
Cross-linker Solution—A 1:1 mixture of H8-BiPS:D8-BiPS was used
for all cross-linking reactions. Cross-linkers were stored as 10 mM
stock solution in DMSO at 20 °C and were added directly to a
solution of the protein in PBS to give a final concentration as de-
scribed below.
Cross-linking of RNase S—RNase S (1 mg/ml in PBS, pH 8.0) was
cross-linked with 0.5 mM BiPS for 30 min at 25 °C. The reaction was
quenched by adding 50 mM ammonium bicarbonate, and proteins
were separated by SDS-PAGE. Protein bands containing cross-
linker were visualized using a UV illuminator with a 362-nm excita-
tion filter. The fluorescent band, corresponding to cross-linked
RNase S, was excised and in-gel digested with porcine trypsin
(sequencing grade, Promega) according to the protocol described
previously (14, 15), separated by HPLC, and analyzed by
MALDI-MS as described below.
Cross-linking of -Arrestins and V2Rpp—The synthesis of phos-
phopeptide V2Rpp and the corresponding non-phosphorylated
peptide, V2Rnp, have been described previously (16). The peptide
sequence is ARGRTPPSLGPQDESCTTASSSLAKDTSS (phospho-
rylated residues are underlined). The procedures for purification of
rat -arrestins has been reported elsewhere (17). Briefly wild-type rat
-arrestin 1 was subcloned into a pGEX4T1 vector and overex-
pressed in Escherichia coli strain BL21(DE3)pLysS. Clarified cell ly-
sate was loaded onto a glutathione-Sepharose column, and -arres-
tin 1 was cleaved from the affinity-bound GST--arrestin 1 by
digestion with thrombin. The cleaved -arrestin 1 was further purified
on a 5-ml HiTrap Mono Q column followed by gel filtration on a
Superdex 75 column. For the cross-linking reaction, two samples
were run in parallel: one with V2Rpp and the other with V2Rnp, both in
a 1:1 ligand:protein ratio. One picomole of -arrestin 1 in PBS buffer,
pH 8.0, was incubated with V2Rpp or V2Rnp and 0.25 mM cross-linker
for 30 min at 25 °C. Unreacted cross-linker was quenched by incu-
bation with 100 mM ammonium bicarbonate for 20 min after which
the sample was separated by SDS-PAGE. Finally the corresponding
protein band was in-gel digested overnight at 25 °C with trypsin (1:10
molar ratio of trypsin to -arrestin) and analyzed by MALDI-MS as
described below.
Rat -arrestin 2 was overexpressed in E. coli as C-terminally His-
tagged protein and was purified using nickel-nitrilotriacetic acid-
Sepharose followed by gel filtration on Superdex 75. Two cross-
linking reactions were run in parallel: with and without V2Rpp. One
nanomole of -arrestin 2 in PBS buffer, pH 8.0, was incubated with
0.25 mM cross-linker for 30 min at 25 °C with or without V2Rpp.
1 The abbreviations used are: MBB, monobromobimane; ICC-
CLASS, isotopically coded cleavable cross-linking analysis software
suite; GPCR, G-protein-coupled receptor; EGSS, ethylene glycol
bis(sulfosuccinimidylsuccinate); V2R, vasopressin type II receptor;
BiPS, bimane bisthiopropionic acid N-succinimidyl ester.
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Unreacted cross-linker was quenched by incubation with 100 mM
ammonium bicarbonate for 20 min, digested with trypsin (1:10
molar ratio) overnight at 37 °C, separated by HPLC, and analyzed by
MALDI-MS as described below.
HPLC Separation of Cross-linked Peptides—Tryptic peptides were
separated and collected (1-ml fractions) by reversed phase HPLC
with fluorescence detection using a 60-min linear gradient of 5–65%
acetonitrile in 0.1% TFA at 1 ml/min on an HP1100 (Agilent) LC
instrument equipped with a Vydac 218TP54 (C18, 5 m, 250  4.6-
mm) column (The Nest Group, Inc., Southborough, MA). Lyophilized
fractions were reconstituted in 10 l of 0.1% TFA, 50% acetonitrile;
mixed with matrix solution; and applied to the MALDI target plate as
described previously (18).
MS Analysis of Cross-linked Peptides—Mass spectrometric anal-
yses were performed on a MALDI-TOF/TOF mass spectrometer (4700
Proteomics Analyzer, Applied Biosystems) operating in the reflectron
mode. MALDI-MS spectra were screened for the presence of ion
signal doublets/multiplets 8.05 and 4.03 Da apart. The screening and
analysis of ion doublets was automated by means of a customized
software program (isotopically coded cleavable cross-linking analysis
software suite (ICC-CLASS)) developed in our laboratory (details to be
published elsewhere).
Briefly the program consists of three modules. The first module,
DXSet, searches the MS mass lists for presence of D8 and D4 peak
doublets. The second module, DXDXMatch, looks for matches for the
D4 and D8 peak doublets according to masses derived from equations
describing the cleavage of different types of cross-links. The third
module, DXMSMSMatch, performs the assignment of uncleaved and
cleaved cross-links based on matching the isotopically coded cross-
linker-containing and cross-linker-free fragment ion masses (from the
MS/MS spectra mass lists) to the theoretically predicted fragment ion
masses. The program is capable of automatic analysis of a set of
multiple spots, for example, from an LC-MALDI analysis.
Doublet peak lists produced by the DXSet module can be down-
loaded as inclusion lists for automatic acquisition of the correspond-
ing MSMS spectra, which in turn can be automatically analyzed by the
DXMSMSMatch module. For the work described here, both doublet
ions were simultaneously selected for tandem analysis by MALDI-
TOF/TOF. For assignment of cross-linked peptides by mass, the
MS-Bridge (Protein Prospector, Mass Spectrometry Facility, Univer-
sity of California San Francisco; bridge elemental composition for
BiPS, C16H16N2O4S2) and ICC-CLASS programs were used to predict
all possible combinations of cross-linked peptide masses. Frag-
ment ions were manually matched to theoretical peptide fragments
calculated by the MS-Product program (Protein Prospector, Uni-
versity of California San Francisco) and by the DXMSMSMatch
module of ICC-CLASS.
Molecular Modeling of the Phosphopeptide V2Rpp--Arrestin In-
teraction Site—We used Medusa (19–21), a general molecular mod-
eling and design program, to determine the structure of the unbound
state of the 29-mer synthetic phosphorylated peptide representing
the C terminus of vasopressin type II receptor. Because the current
version of Medusa contains no force field for phosphate groups, we
substituted all the phosphorylated residues with glutamic acid to
mimic the negatively charged phosphoryl groups. We also incorpo-
rated the distance constraints that represent known secondary struc-
ture information to force the sampled conformations to be consistent
with the conserved secondary structure prediction by the PHD pro-
gram (22). We performed a replica-exchange molecular dynamics
simulation (23) with eight replicas at temperatures from 0.4 to 0.63
(temperature is in the unit of /kB where  is the energy unit and kB is
the Boltzmann constant) for 105 time units. These replica-exchange
simulations were followed by annealing simulations of each replica for
104 time units to a temperature of 0.1. From eight annealing simula-
tions, we chose the conformations with the lowest energies, and that
were consistent with the known secondary structure information.
Next we used a well established docking program, ZDOCK (24, 25),
to determine the structure of the phosphopeptide--arrestin complex
based on the calculated structures of each component. Among the
predicted structures for the complex, we chose the structure with the
least violation of experimentally derived cross-linking constraints from
the structures with the lowest energies as the structural template for
further refinement. Finally we used Medusa to refine the predicted
structure of the phosphopeptide--arrestin complex so that the re-
sulting structure of the complex satisfied all experimentally derived
cross-linking constraints. In this complex, the phosphopeptide binds
to the concave surface of the -arrestin N-domain.
RESULTS AND DISCUSSION
Design and Analytical Characteristics of the Fluorescent,
Photocleavable, and Isotopically Coded Cross-linker BiPS—In
previous studies, we found that the modification of cysteine
residues by MBB, a commercially available fluorescent label
for thiol groups, was partially reversible during MALDI-MS
(10). Based on this finding, we synthesized a novel dibromo-
bimane-derived cross-linker that is fluorescent and
MALDI-MS photocleavable (Fig. 1A). The two bromine atoms
of dibromobimane were reacted with thiol groups of mercap-
topropionic acid, leading to the formation of thioesters of
mercaptopropionic acid. To obtain a homobifunctional amino-
reactive cross-linker, bimanedicarboxylic acid was activated
with N-hydroxysuccinimide to form a di(N-hydroxysuccinimi-
dyl) derivative that we call H8-BiPS (X  H in Fig. 1A). To
facilitate the detection of the cross-linked peptides in the
mass spectra, we also synthesized an isotopically labeled
BiPS (D8-BiPS; X  D in Fig. 1A) derivative by using deuter-
ated mercaptopropionic acid (d4-mercaptopropionic acid)
synthesized from commercially available d4-bromopropionic
acid. This D8-BiPS contains eight deuterium atoms in the
aliphatic chain of the propionic acid portions of the molecule.
The bimane moiety of BiPS gives rise to its fluorescent prop-
erties with excitation and emission maxima of 370 and 480
nm, respectively. Fluorescence provides much higher sensi-
tivity then UV absorption and consequently can be used to
facilitate the detection and separation of low-abundance
cross-linked peptides. The maximum span of the cross-linker
is 10 Å. The real spacing, however, was probably somewhat
less because of the planar character of the bimane-fused
heterocyclics.
Characteristic Mass Spectrometric Signatures of MALDI-
MS-induced Fragmentation of BiPS—Based on previous ob-
servations, we predicted that MALDI conditions would lead to
photoinduced cleavage of BiPS-cross-linked peptides in a
manner analogous to MBB-modified cysteines. Fragmenta-
tion occurs at two specific sites that are adjacent to the sulfur
atom (Fig. 1B). Photocleavage produces two halves of the
cross-linked peptides, both of which are isotopically labeled
with four deuterium atoms in the propionic acid moiety of the
cross-linker. If a 1:1 mixture of H8-BiPS/D8-BiPS is used, this
photocleavage generates ion signal doublets at a 1:1 ratio and
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FIG. 1. MALDI-induced photocleav-
age of BiPS in cross-links. A, chemical
structure of H8/D8-BiPS. B–D, scheme
of the ion signals detectable in the
MALDI-MS analysis of BiPS interpeptide
(B), BiPS dead-end (C), and BiPS in-
trapeptide (D) cross-links. The ion sig-
nals are annotated by the chemical
structures proposed for BiPS-containing
peptides obtained after MALDI-induced
fragmentation with thiopropionic (T), bi-
mane (Bi), peptide (P), and hydroxyl (OH)
moieties. “Lightning”-like arrows (4I) in-
dicate sites of photocleavage. E, sche-
matic of ICC-CLASS analysis using iso-
topic coding and cleavage features of
BiPS.
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4.03 Da apart. Moreover because of the symmetrical nature of
the cross-linker, the cleavage can occur with equal probability
at either of the two sulfur atoms, thus producing two 4.03-Da
doublets separated by a mass difference of 190.07 Da, a
difference corresponding to the mass of the bimane moiety of
the cross-linker.
As we demonstrated previously for the chemically cleav-
able, isotopically coded cross-linker D12-EGSS (9), cross-
linker cleavage facilitates analysis of the cross-linked pep-
tides. Cleavage enables the researcher to distinguish between
different types of cross-links (dead end, intra-, or interpep-
tide). Most importantly, cross-linker cleavage permits accu-
rate mass determination and sequence analysis of the indi-
vidual peptides constituting the cross-link, thus facilitating
identification of cross-linked peptides and cross-linking sites.
All of these benefits are provided by the photoinducible cleav-
age of BiPS. Moreover because the cleavage occurs during
MALDI-MS, sample loss is negligible. This is in contrast to
chemical cross-linker cleavage, which is typically not per-
formed in situ and requires an additional purification step that
may lead to sample loss.
Dead-end BiPS cross-links can be assigned based on the
occurrence of two 4.03-Da ion doublets that are 104 and 294
Da lower than the mass of the 8.05-Da doublet of the non-
cleaved cross-links (Fig. 1C). Individual peptides derived from
cleavage of BiPS interpeptide cross-links appear as doublets
separated by 4.03 Da with the m/z values of the singly
charged modified peptide equal to the mass of the unmodified
uncharged peptide plus 89 and/or 279 Da.
According to our studies on H8-BiPS/D8-BiPS-cross-linked
peptides (data not shown), photocleavage of intrapeptide
cross-links results in the formation of a disulfide-containing
peptide that occurs as an 8.05-Da ion doublet that is 190 Da
lower in mass than the intrapeptide cross-link (Fig. 1D). The
masses of individual peptides obtained by photocleavage are
related to the mass of the original non-cleaved cross-link
according to the equations shown in Fig. 1, B–D. These math-
ematical relationships provide further verification of assigned
cross-link types.
Recently we developed a simple-to-use software algorithm
for automatic detection and identification of H12-EGSS/D12-
EGSS cross-link types (9). Based on this algorithm, we devel-
oped a software package called ICC-CLASS to carry out fully
automated detection and assignment of isotopically coded
cleavable dead-end, intra-, and interpeptide cross-links (Fig.
1E). The ICC-CLASS program can also generate lists of
masses, including BiPS-containing uncleaved and cleaved
cross-links, and these lists can be downloaded for automated
MS/MS acquisition on a MALDI-TOF/TOF instrument. More-
over ICC-CLASS is capable of analyzing and interpreting
MS/MS spectra by assigning fragment ions from isotopically
coded cross-links from protein complexes to known se-
FIG. 1—continued
BiPS, a MALDI-cleavable Cross-linker for Structural Proteomics
Molecular & Cellular Proteomics 8.2 277
quences. When combined with GPS ExplorerTM or Mascot
analysis of MS/MS data for individual peptides obtained after
cross-linker cleavage, ICC-CLASS can be used to identify
unknown dead-end, inter-, and intrapeptide cross-links. This
program is designed as an integrated software/instrument
platform allowing a completely automated and targeted anal-
ysis of isotopically coded cross-links from data acquisition by
MALDI-MS and -MS/MS to the assignment and identification
of the cross-links.
Model Protein Complex RNase S—To evaluate the applica-
bility of BiPS and ICC-CLASS to protein cross-linking studies,
we cross-linked the model complex RNase S, a small protein
heterodimer consisting of a 20-mer S-peptide and a 14-kDa
core protein. The cross-linking was performed with a 1:1
mixture of H8-BiPS and D8-BiPS, the reaction was quenched
with ammonium bicarbonate, and the components were sep-
arated by SDS-PAGE. Protein bands containing BiPS can be
conveniently visualized under UV light with a standard UV light
box typically used for ethidium bromide-stained DNA agarose
gels (Fig. 2A).
The upper band in Fig. 2A corresponds to the BiPS-cross-
linked complex, whereas the lower band represents dead-end
derivatives of the RNase S core. The upper band was sub-
jected to in-gel proteolytic digestion, and the extracted pep-
tides were separated using reversed-phase HPLC with fluo-
rescence detection (Fig. 2B). It is worth noting that the degree
of completeness of the digestion can be determined by mon-
itoring the fluorescence of the extracted peptides compared
with the residual fluorescence of the protein band in the gel.
Although the UV absorbance of the peptides during HPLC
was practically undetectable (data not shown), the fluores-
cence chromatogram did reveal the target cross-linked pep-
tides (Fig. 2B). The small volume of sample required and
increased sensitivity of fluorescence detection versus UV de-
tection are compatible with nano-LC. This can make BiPS
cross-linking suitable for electrospray LC-MS approaches
with on-line fluorescence detection. On-line fluorescence de-
tection could be used to develop a sensitive and accurate
quantitative and qualitative analysis in which fluorescence-
dependent MS/MS acquisition could be used for selective
analysis of BiPS-containing peptides. This highly sensitive
and quantitative method could be useful in probing changes
in protein structure, including the detection of minor confor-
mational alterations of potential biological significance.
For off-line separation, MALDI-MS is advantageous be-
cause of the partial cleavage of BiPS under MALDI-MS con-
ditions and the capacity for reanalysis of the same sample
spots. Fig. 2C depicts the MALDI spectrum of a fluorescent
fraction from an HPLC separation of cross-linked RNase S
after proteolysis. Two BiPS-containing peptides and their as-
sociated photocleaved fragmentation products are indicated
by two doublets 8.05 Da apart (at m/z 1256.73 and m/z
1532.88) and four doublets 4.03 Da apart, respectively. ICC-
CLASS assigned the doublet at m/z 1256.73 as an interpep-
tide cross-link, whereas the doublet at m/z 1532.88 was as-
signed as a dead-end cross-link based on the specific MS
signatures of the cross-link types (see above). MS/MS anal-
ysis of the peptides induced by photocleavage of the cross-
linker followed by computerized assignment of the sequence-
specific ions via ICC-CLASS provided unambiguous
identification of the BiPS-cross-linked peptides (Fig. 2D and
Table I).
Detailed examination of the x-ray crystallographic structure
of RNase S S-protein and S-peptide binding sites revealed
that the structural information obtained from the cross-linked
peptides agrees well with our protein-protein interaction site
data because the distances between cross-linked sites are
within the maximum span of the cross-linker (26). Thus, these
experiments demonstrate the feasibility of using BiPS to
structurally characterize protein-protein interaction sites as
well as the capability of ICC-CLASS to facilitate detection,
assignment, and identification of cross-links.
Protein-Protein Interaction of the Vasopressin Receptor C
Terminus and -Arrestin 1—We next applied this methodol-
ogy to the elucidation of the protein-protein interaction site
between vasopressin type II receptor (V2R), a member of the
seven transmembrane-spanning G-protein-coupled receptor
family, and its adaptor, -arrestin. Previously we developed
an in vitro receptor--arrestin interaction model using a 29-
mer synthetic multiphosphopeptide (V2Rpp) derived from the
phosphorylated C terminus of V2R. We demonstrated that
V2Rpp bound to -arrestin and simulated the effects of an
activated phosphorylated GPCR, whereas the corresponding
nonphosphorylated peptide, V2Rnp, had no effect (16). This in
vitro model represents a simplified receptor--arrestin inter-
action system in which the binding site for the V2Rpp on
-arrestin represents that for the phosphorylated C terminus
of the receptor.
To locate the binding site of V2Rpp on -arrestin, -arrestin
2 was cross-linked with and without V2Rpp using a 1:1 mix-
ture of H8-BiPS and D8-BiPS. Reaction mixtures were di-
gested with trypsin, the resulting peptides were separated by
reversed-phase HPLC with on-line fluorescence detection,
and the fluorescent fractions were analyzed by MALDI-MS
and MALDI-MS/MS (Table II, part A). Alternatively cross-
linked reaction mixtures of -arrestin 1 with V2Rpp or V2Rnp
were separated by SDS-PAGE, and the protein bands were
excised and in-gel digested with trypsin. The resulting tryptic
peptides were analyzed by MALDI-MS and MALDI-MS/MS
(Table II, part B).
The utility of this methodology is shown in Fig. 3, A and B.
Although the MS spectrum shows numerous ion signals, the
ICC-CLASS program detected doublets of ion signals 8.05 Da
apart that correspond to the interpeptide cross-link as well as
doublets 4.03 Da apart that represent individual peptides
released by MALDI photocleavage of the cross-link. No -ar-
restin-V2Rnp interpeptide cross-link was observed when the
corresponding non-phosphorylated peptide, V2Rnp, was
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used (data not shown). Subsequent MS/MS analysis of the
peptides constituting the cross-link allowed unambiguous
identification of the cross-link site (Fig. 3B). These results
demonstrate an interaction between the N terminus of V2Rpp
and lysine 85 of -arrestin 1 that is located in -sheet VII of the
N-domain. Further support for this interaction was provided
by additional interpeptide cross-links between the N terminus
of V2Rpp and lysine 11 of -arrestin 2 that were also assigned
and identified using the ICC-CLASS software (Table II, part A).
These data are in agreement with the current receptor-arrestin
FIG. 2. BiPS cross-linking followed by MALDI-MS analysis using RNase S heterodimer as a model complex. A, gel image under UV
illumination from SDS-PAGE analysis of RNase S after cross-linking with BiPS. The upper fluorescent band relates to the heterodimer of RNase
S cross-linked by BiPS. B, HPLC with fluorescence detection (excitation, 370 nm; emission, 480 nm) of BiPS-cross-linked RNase S after
SDS-PAGE separation of the cross-linked complex followed by in-gel digestion with trypsin. The dotted line corresponds to the fluorescence
chromatogram of HPLC analysis of a blank piece of gel after in-gel digestion as a negative control. C, MALDI-MS analysis of a fluorescent
HPLC fraction containing BiPS interpeptide and dead-end peptide cross-links of RNase S. The ion signals are annotated with m/z values and
assigned to BiPS-containing peptides and photolysis products of BiPS cross-links, based on their mass, doublet formation, and masses
relative to other doublets of ion signals. D, MS/MS analysis of the ion doublet with m/z 834.52 and 838.54. The sequence-specific b- and y-ions
are assigned, resulting in complete sequencing of the peptide representing the BiPS interpeptide cross-links of RNase S released by
photocleavage of the cross-linker. LU, luminescence units.
BiPS, a MALDI-cleavable Cross-linker for Structural Proteomics
Molecular & Cellular Proteomics 8.2 279
FIG. 2—continued
BiPS, a MALDI-cleavable Cross-linker for Structural Proteomics
280 Molecular & Cellular Proteomics 8.2
TABLE I
RNAse S BiPS cross-links
Assigned tryptic cross-links from HPLC fractions 13–36 of in-gel tryptic digest of BiPS-cross-linked RNAse S are shown. D8 obs and D8 calc,
observed and calculated D8 peak doublets, respectively; D8, mass error for D8 peak doublets (D8  MD8  MH8  8.05021 Da); CL type,
cross-link type (i, intrapeptide; OH and NH2, carboxyl and amide dead end, respectively; ip, interpeptide); C, protein chain of RNAse S; Sr,
starting peptide amino acid residue; Er, ending peptide amino acid residue; D4 obs and D4 calc, observed and calculated D4 peak doublets of
photocleaved products, respectively; D4, mass error for D4 peak doublets (D4  MD4  MH4 4.02511 Da); T, thiopropionic moieties of the
cross-linker; Bi, bimane moieties of the cross-linker (see Fig. 1). Residues in parentheses represent residues preceding and following the
enzymatic digestion site. Dashes in parentheses correspond to the N or C terminus.
D8 obs D8 calc D8 CL type C Sr Er Sequence D4 obs D4 calc D4 Cleaved products
Da Da Da Da Da Da
1082.60 1082.46 0.00 i 1 1 7 (–)KETAAAK(F) 892.39a 1T-T
1100.62 1100.48 0.00 1-OH 1 1 7 (–)KETAAAK(F) 806.41 1T
996.63 996.48 0.04 1T-Bi
1127.68 1127.50 0.00 1-NH2 2 14 19 (R)NLTKDR(C) 834.55 834.41 0.00 1T
1024.65 1024.49 0.00 1T-Bi
1128.65 1128.48 0.00 1-OH 2 14 19 (R)NLTKDR(C) 834.55 834.41 0.00 1T
1024.64 1024.49 0.00 1T-Bi
1256.74 1256.58 0.00 ip 2 14 19 (R)NLTKDR(C) 834.53 834.41 0.00 1T
1024.62 1024.49 0.00 1T-Bi
1 1 1 (–)K(E) 235.11 1T
425.19 1T-Bi
1403.83 1403.61 0.00 1-NH2 1 2 10 (K)ETAAAKFER(Q) 1110.69 1110.52 0.00 1T
1300.79 1300.60 0.00 1T-Bi
1404.80 1404.59 0.00 1-OH 1 2 10 (K)ETAAAKFER(Q) 1110.68 1110.52 0.00 1T
1300.78 1300.60 0.00 1T-Bi
1482.77 1482.54 0.00 2-OH 1 1 7 (–)KETAAAK(F) 894.41 2T
1084.64 1084.48 0.01 1T, 1T-Bi
1274.55 2T-Bi
1188.47 1T, 1T-Bi-T-OH
1378.83 1378.55 0.05 1T-Bi, 1T-Bi-T-OH
1514.90 1514.68 0.00 i 1 1 10 (–)KETAAAKFER(Q) 1324.79a 1324.60a 0.00 1T-T
1532.88 1532.69 0.00 1-OH 1 1 10 (–)KETAAAKFER(Q) 1238.77 1238.62 0.00 1T
1428.87 1428.69 0.00 1T-Bi
1828.92 1828.73 0.02 1-NH2 2 66 78 (R)ETGSSKYPNCAYK(T) 1535.65 1T
1725.72 1T-Bi
1830.00 1829.72 0.02 1-OH 2 66 78 (R)ETGSSKYPNCAYK(T) 1535.85 1535.65 0.02 1T
1725.99 1725.72 0.01 1T-Bi
1883.07 1882.79 0.02 1-NH2 2 72 84 (K)YPNCAYKTTQANK(H) 1589.93 1589.71 0.00 1T
1779.78 1T-Bi
1884.07 1883.78 0.01 1-OH 2 72 84 (K)YPNCAYKTTQANK(H) 1589.93 1589.71 0.01 1T
1780.03 1779.78 0.00 1T-Bi
1897.03 1896.74 0.00 i, 1-OH 1 1 10 (–)KETAAAKFER(Q) 1412.85 1412.60 0.03 1T-T, 1T
1602.92 1602.67 0.02 1T-T, 1T-Bi; 1T-Bi-T, 1T
1706.94 1706.67 0.01 1T-T, 1T-Bi-T-OH
1793.01 1792.75 0.00 1T-Bi-T, 1T-Bi
1899.98 1899.70 0.01 i 2 1 13 (–)SSSNYCNQMMKSR(N) 1709.62a 1T-T
1812.93 1812.66 0.01 i 2 2 13 (–)SSNYCNQMMKSR(N) 1622.59a 1T-T
1915.02 1914.75 0.02 2-OH 1 1 10 (–)KETAAAKFER(Q) 1326.62 2T
1516.69 1T, 1T-Bi
1706.77 2T-Bi
1620.92 1620.69 0.03 1T, 1T-Bi-T-OH
1811.01 1810.76 0.02 1T-Bi, 1T-Bi-T-OH
1918.03 1917.71 0.01 1-OH 2 1 13 (–)SSSNYCNQMMKSR(N) 1623.92 1623.64 0.01 1T
1814.01 1813.71 0.00 1T-Bi
2624.58 2624.14 0.06 i, ip 1 1 10 (–)KETAAAKFER(Q) 1412.84 1412.60 0.02 1T-T, 1T
1602.92 1602.67 0.01 1T-T, 1T-Bi; 1T-Bi-T, 1T
2434.15 2434.07 0.03 1T-T, 1T-Bi-T-P2
1793.01 1792.75 0.00 1T-Bi-T, 1T-Bi
2 14 19 (R)NLTKDR(C) 834.55 834.41 0.00 1T
1024.64 1024.49 0.01 1T-Bi
a D8 peak doublet, cleaved products as in Fig. 1.
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TABLE II
V2R phosphopeptide--arrestin BiPS cross-links
Part A, assigned tryptic cross-links from HPLC fractions 13–36 of in-solution tryptic digest of BiPS-cross-linked V2Rpp--arrestin 2. Part B,
assigned tryptic cross-links from in-gel digest of BiPS-cross-linked V2Rpp--arrestin 1. Abbreviations are the same as in Table I. Residues in
parentheses represent residues preceding and following the enzymatic digestion site. Dashes in parentheses correspond to the N or C
terminus.
D8 obs D8 calc D8 CL type C Sr Er Sequence D4 obs D4 calc D4 Cleaved products
Da Da Da Da Da Da
A
902.41 902.43 0.00 1-NH2 1 16 19 (R)VFKK(S) 609.29 613.34 0.02 1T
799.37 799.42 0.02 1T-Bi
903.42 903.41 0.00 1-OH 1 16 19 (R)VFKK(S) 609.34 609.34 0.00 1T
799.41 799.42 0.00 1T-Bi
908.40 908.39 0.00 1-NH2 1 166 169 (K)SHKR(N) 615.30 615.30 0.01 1T
805.39 805.38 0.00 1T-Bi
909.35 909.37 0.00 1-OH 1 166 169 (K)SHKR(N) 615.29 615.30 0.00 1T
805.35 805.38 0.01 1T-Bi
958.45 958.42 0.00 1-OH 1 404 408 (R)LKGMK(D) 664.35 1T
854.43 1T-Bi
998.40 998.38 0.00 1-NH2 1 1 6 (–)GSPNSR(V) 705.31 705.30 0.00 1T
895.38 895.37 0.01 1T-Bi
999.35 999.37 0.00 1-OH 1 1 6 (–)GSPNSR(V) 705.26 705.30 0.00 1T
895.33 895.37 0.00 1T-Bi
1144.40 1144.46 0.01 1-NH2 1 19 25 (K)KSSPNCK(L) 851.34 851.38 0.01 1T
1041.36 1041.45 0.04 1T-Bi
1182.64 1182.60 0.00 1-OH 1 334 340 (K)VKLVVSR(G) 888.53 1T
1078.43 1078.61 0.07 1T-Bi
1296.57 1296.68 0.03 ip 1 292 294 (R)EKR(G) 520.29 520.26 0.03 1T
710.33 1T-Bi
1 112 115 (R)LLKK(L) 589.37 1T
779.45 1T-Bi
1331.66 1331.65 0.00 1-OH 1 26 33 (K)LTVYLGKR(D) 1037.60 1037.58 0.01 1T
1227.67 1227.66 0.00 1T-Bi
1339.56 1339.58 0.00 1-NH2 1 7 15 (R)VDGEKPGTR(V) 1046.48 1046.49 0.00 1T
1236.55 1236.57 0.00 1T-Bi
1340.54 1340.56 0.00 1-OH 1 7 15 (R)VDGEKPGTR(V) 1046.48 1046.49 0.00 1T
1236.55 1236.57 0.00 1T-Bi
1357.74 1357.74 0.09 ip 1 332 335 (R)VKVK(L) 561.34 1T
751.42 1T-Bi
1 16 19 (R)VFKK(S) 609.34 609.34 0.00 1T
799.41 799.42 0.00 1T-Bi
1411.60 1411.70 0.02 ip 1 16 19 (R)VFKK(S) 609.34 1T
799.31 799.42 0.00 1T-Bi
1 166 169 (K)SHKR(N) 615.29 615.30 0.00 1T
805.35 805.38 0.01 1T-Bi
1501.68 1501.69 0.00 ip 1 16 19 (R)VFKK(S) 609.29 609.34 0.03 1T
799.34 799.42 0.03 1T-Bi
1 1 6 (–)GSPNSR(V) 705.26 705.30 0.00 1T
895.33 895.37 0.00 1T-Bi
1567.70 1567.70 0.03 ip 2 1 2 (–)AR(G) 334.15 1T
524.22 524.23 0.00 1T-Bi
1 7 15 (R)VDGEKPGTR(V) 1046.47 1046.49 0.00 1T
1236.54 1236.57 0.01 1T-Bi
1791.77 1791.81 0.00 1-OH 1 20 32 (K)SSPNCKLTVYLGK(R) 1497.71 1497.74 0.01 1T
1687.83 1687.82 0.02 1T-Bi
1822.92 1822.92 0.00 ip 1 112 115 (R)LLKK(L) 589.37 1T
779.45 1T-Bi
1 7 15 (R)VDGEKPGTR(V) 1046.49 1046.49 0.02 1T
1236.56 1236.57 0.01 1T-Bi
1842.85 1842.89 0.00 ip 1 16 19 (R)VFKK(S) 609.29 613.34 0.02 1T
799.37 799.42 0.02 1T-Bi
1 7 15 (R)VDGEKPGTR(V) 1046.46 1046.49 0.00 1T
1236.52 1236.57 0.00 1T-Bi
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interaction model (27) and provide the first direct experimental
evidence for the location of the binding site of the C terminus
of GPCR to the -arrestin molecule.
To further characterize the protein-protein interaction site,
we computationally predicted the secondary structure of the
29-mer phosphopeptide that represents the C terminus of
V2R. Using the x-ray structure of -arrestin, we then used
molecular modeling programs to compute the structure of the
phosphopeptide--arrestin complex by utilizing experimen-
tally derived cross-linking constraints (Fig. 3C). The computed
structure of the complex shows that V2Rpp binds to the
concave surface of the -arrestin N-domain.
By using a methodology combining MS and our BiPS
cross-linker, we successfully mapped the binding site of a
receptor C terminus on the multifunctional scaffold and adap-
tor protein -arrestin, thus paving the way toward elucidating
the structural basis of this dynamic receptor--arrestin inter-
action. Our findings will aid in the understanding not only of
the regulatory mechanism of a wide variety of GPCR-medi-
ated physiological cellular processes but also of the molecular
TABLE II—continued
D8 obs D8 calc D8 CL type C Sr Er Sequence D4 obs D4 calc D4 Cleaved products
Da Da Da Da Da Da
A
1877.78 1877.73 0.00 2-OH 1 161 169 (K)SIEEKSHKR(N) 1289.58 1289.60 0.06 2T
1479.72 1479.67 0.01 1T, 1T-Bi
1669.76 1669.75 0.00 2T-Bi
1583.71 1583.67 0.00 1T, 1T-Bi-T-OH
1773.78 1773.74 0.01 1T-Bi, 1T-Bi-T-OH
1938.84 1938.84 0.00 ip 1 1 6 (–)GSPNSR(V) 705.30 705.30 0.00 1T
895.37 895.37 0.00 1T-Bi
1 7 15 (R)VDGEKPGTR(V) 1046.50 1046.49 0.00 1T
1236.57 1236.57 0.00 1T-Bi
2295.05 2295.04 0.00 1-NH2 1 304 321 (K)HEDTNLASSTIVKEGANK(E) 2002.00 2001.96 0.02 1T
2192.03 1T-Bi
2423.14 2423.10 0.02 1-OH 1 178 196 (R)KVQFAPETPGPQPSAETTR(H) 2129.08 2129.03 0.02 1T
2319.11 1T-Bi
2459.13 2459.15 0.04 1-OH 1 7 25 (R)VDGEKPGTRVFKKSSPNCK(L) 2165.03 2165.08 0.00 1T
2355.11 2355.16 0.01 1T-Bi
2691.32 2691.31 0.02 1-NH2 1 295 316 (R)GLALDGQLKHEDTNLASSTIVK(E) 2398.23 2398.23 0.00 1T
2588.30 2588.30 0.01 1T-Bi
2692.28 2692.30 0.00 1-OH 1 295 316 (R)GLALDGQLKHEDTNLASSTIVK(E) 2398.20 2398.23 0.01 1T
2588.28 2588.30 0.01 1T-Bi
3105.58 3105.53 0.01 ip 1 292 294 (R)EKR(G) 520.27 520.26 0.03 1T
710.34 710.33 0.01 1T-Bi
1 295 316 (R)GLALDGQLKHEDTNLASSTIVK(E) 2398.21 2398.23 0.00 1T
2588.35 2588.30 0.03 1T-Bi
B
1227.47 1227.49 0.01 1NH2 1 1 8 (–)GSPEFPGR(L) 934.40 934.41 0.01 1T
1124.46 1124.48 0.00 1T-Bi
1228.46 1228.48 0.00 1OH 1 1 8 (–)GSPEFPGR(L) 934.40 934.41 0.01 1T
1124.46 1124.48 0.00 1T-Bi
1331.53 1331.65 0.02 1OH 1 26 33 (K)LTVYLGKR(D) 1037.53 1037.58 0.05 1T
1227.61 1227.66 0.01 1T-Bi
1833.86 1833.98 0.01 ip 1 16 19 (R)VFKK(A) 609.34 1T
799.42 1T-Bi
1 26 33 (K)LTVYLGKR(D) 1037.53 1037.58 0.05 1T
1227.61 1227.66 0.01 1T-Bi
1955.85 1955.87 0.01 ip 1 9 15 (R)LGDKGTR(V) 834.41 834.41 0.01 1T
1024.47 1024.49 0.00 1T-Bi
1 1 8 (–)GSPEFPGR(L) 934.40 934.41 0.01 1T
1124.46 1124.48 0.00 1T-Bi
2383.09 2383.11 0.01 1NH2 1 85 102 (R)KDLFVANVQSFPPAPEDK(K) 2090.00 2090.03 0.00 1T
2280.08 2280.10 0.02 1T-Bi
2611.22 2611.23 0.00 ip 2 1 2 (–)AR(G) 334.15 1T
524.33 524.23 0.00 1T-Bi
1 85 102 (R)KDLFVANVQSFPPAPEDK(K) 2090.00 2090.03 0.00 1T
2280.08 2280.10 0.02 1T-Bi
3378.60 3378.59 0.02 1OH 1 34 59 (R)DFVDHIDLVDPVDGVVLVDPEYLKER(R) 3084.52 3084.52 0.04 1T
3274.58 3274.60 0.00 1T-Bi
BiPS, a MALDI-cleavable Cross-linker for Structural Proteomics
Molecular & Cellular Proteomics 8.2 283
basis of numerous clinical diseases associated with dysregu-
lation of GPCR signaling.
Conclusions—In conclusion, we report here the synthesis
and application of the novel cross-linker BiPS. BiPS is distin-
guished from other reagents by a unique combination of
chemical groups that render it homobifunctional, amine-reac-
tive, isotopically coded, fluorescent, and photocleavable un-
der MALDI-MS conditions. These characteristics facilitate the
detection and identification of cross-linked proteins and
BiPS-containing peptides (cross-links).
Our study of the RNase S model protein complex demon-
strated that fluorescence assists in both the detection of
cross-linked proteins in a gel and fluorescent cross-links dur-
ing the HPLC separation. The isotopic coding facilitates the
process of MS detection of the cross-link and its constituent
peptides released after cross-linker photocleavage. The ben-
efits of the partial photoinduced cleavage of BiPS in
MALDI-MS experiments are 2-fold. First, the masses and
mass differences of the peptides obtained by photocleavage
of BiPS are in a defined relation to each other, providing MS
signatures for immediate assignment of cross-link types
(dead end, intra-, or interpeptide). Second, the identification
of cross-links is greatly improved because separate MS/MS
analyses of the individual cross-linked peptides can be per-
formed. A software program we developed termed ICC-
CLASS uses these MS features for automated detection, as-
signment, and identification of BiPS cross-links.
The unique advantages of BiPS and the automation capa-
bilities provided by ICC-CLASS facilitate the use of this cross-
linking approach for structural studies in biological systems
where other structural analysis methods are limited, for ex-
ample in the study of receptor proteins. In this study, we
describe the successful identification of the binding site of a
phosphopeptide mimicking the phosphorylated C terminus of
FIG. 3. Identification of the V2R C terminus binding site on -arrestin by BiPS cross-linking. A, MALDI-MS analysis of a BiPS
interpeptide cross-link, V2R phosphopeptide--arrestin 1. BiPS cross-links lysine 85 of the tryptic peptide (
85KDLFVANVQSFPPAPEDK102)
from -arrestin 1 and the N-terminal alanine of the tryptic peptide (1AR2) from V2Rpp. The doublet peaks of the interpeptide and its
photocleaved products are enlarged and shown in the insets. B, tandem mass spectra of the individual peptides released by photocleavage
of the interpeptide cross-link. C, location and modeling of the interaction site of V2R phosphopeptide--arrestin. Shown is the predicted
structure of the V2R phosphopeptide--arrestin complex computed by molecular modeling to fit the constraints of the experimentally identified
interaction between the N terminus of the V2R phosphopeptide and -arrestins.
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FIG. 3—continued
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V2R to its adaptor, -arrestin. This combination of cross-linker
and software should be useful for mapping the docking sites
of the intact receptor and arrestin or even more complex
signaling modules, or signalosomes, either in vitro or in vivo.
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